Apical-height dosing produces outcomes comparable to 5-mm dosing
Produces favorable oncologic outcomes, wound healing and quality of life
Positioning the technology in the current therapeutic landscape
First step toward testing therapeutics
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advanced radiotherapy in a rare soft-tissue sarcoma
Why experts advise against it for breast, skin and gynecologic cancers
13-year retrospective shows evolution of treatment for aggressive disease
Pushing the envelope in musculoskeletal oncology care
Efficacy similar to IMRT with less toxicity
Despite DES, restenosis remains a risk